Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer After a Radical Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002874
What this trial is testing

Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 840
Testing effectiveness (Phase 2)Study completedNCT02543255
What this trial is testing

Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)

Who this might be right for
Prostate Cancer
University Health Network, Toronto 76
Large-scale testing (Phase 3)Study completedNCT00283062
What this trial is testing

Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy

Who this might be right for
Prostatic Neoplasms
Sanofi 228
Testing effectiveness (Phase 2)Study completedNCT03617588
What this trial is testing

68Ga-THP-PSMA PET/CT Imaging in High Risk Primary Prostate Cancer or Biochemical Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer
Theragnostics Ltd 49
Not applicableStudy completedNCT00335634
What this trial is testing

Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer Surgery

Who this might be right for
Prostate CancerErectile Dysfunction Following Radical ProstatectomySexual Dysfunction
University Health Network, Toronto 50
Testing effectiveness (Phase 2)Study completedNCT00223665
What this trial is testing

Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 102
Testing effectiveness (Phase 2)Study completedNCT00558363
What this trial is testing

ARTS - AVODART After Radical Therapy For Prostate Cancer Study

Who this might be right for
Neoplasms, ProstateProstate Cancer After a Radical Treatment
GlaxoSmithKline 294
Testing effectiveness (Phase 2)Looking for participantsNCT06449781
What this trial is testing

177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Maria Sklodowska-Curie National Research Institute of Oncology 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05778097
What this trial is testing

Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study)

Who this might be right for
Prostate CancerBiochemical RecurrenceHigh Risk
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 103
Large-scale testing (Phase 3)Active Not RecruitingNCT04484818
What this trial is testing

Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study

Who this might be right for
Prostate Carcinoma
ECOG-ACRIN Cancer Research Group 27
Testing effectiveness (Phase 2)Study completedNCT00203424
What this trial is testing

Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib

Who this might be right for
Prostate Cancer
Translational Oncology Research International 23
Testing effectiveness (Phase 2)Study completedNCT00230438
What this trial is testing

External Beam Radiation Therapy - Target Volume

Who this might be right for
Prostatic Neoplasms
University Health Network, Toronto 27
Testing effectiveness (Phase 2)Looking for participantsNCT06305832
What this trial is testing

Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer

Who this might be right for
Prostate CancerBiochemical Recurrence
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 102
Testing effectiveness (Phase 2)Study completedNCT03311555
What this trial is testing

A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR)

Who this might be right for
Prostate Cancer
Andrew J. Armstrong, MD 39